TokenPost·
MaxCyte Agrees to Acquire Akron Bio in $151.8 Million Deal
The proposed transaction includes $105 million in cash, shares valued at about $26.8 million and $20 million in guaranteed deferred payments.
More news
- TokenPostPeter Schiff Puts Bitcoin’s Cycle-Low Estimate Near $59,517
- TokenPostHesai Projects Q4 Net Revenue of RMB 1.1 Billion to RMB 1.15 Billion
- TokenPostLiquidia Sets 2028 PH-ILD Goal, 2029 L606 NDA Submission Target
- TokenPostOura to Acquire Counsel Health in $625 Million Cash Deal
- TokenPost3,500 Bitcoin Transfer Leads $1.48 Billion in Three-Hour Crypto Moves
- TokenPostPompliano Names Bitcoin (BTC), Gold and Productive Land as Inflation Hedges